TY  - GEN
AU  - Ritchlin,Christopher T
AU  - Kavanaugh,Arthur
AU  - Merola,Joseph F
AU  - Schett,Georg
AU  - Scher,Jose U
AU  - Warren,Richard B
AU  - Gottlieb,Alice B
AU  - Assudani,Deepak
AU  - Bedford-Rice,Kathy
AU  - Coarse,Jason
AU  - Ink,Barbara
AU  - McInnes,Iain B
TI  - Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial
SN  - 1474-547X
PY  - 2020///0303
KW  - Adult
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Arthritis, Psoriatic
KW  - drug therapy
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Injections
KW  - Interleukin-17
KW  - antagonists & inhibitors
KW  - Male
KW  - Middle Aged
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1016/S0140-6736(19)33161-7
ER  -